Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Armata Pharmaceuticals (ARMP) EBIT Margin (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed EBIT Margin for 6 consecutive years, with 862.35% as the latest value for Q4 2018.

  • Quarterly EBIT Margin rose 1268735.0% to 862.35% in Q4 2018 from the year-ago period, while the trailing twelve-month figure was 1219.41% through Dec 2018, up 1526810.0% year-over-year, with the annual reading at 313.49% for FY2025, 44865.0% down from the prior year.
  • EBIT Margin hit 862.35% in Q4 2018 for Armata Pharmaceuticals, up from 791.21% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 1011.74% in Q2 2018 to a low of 53927.27% in Q4 2016.
  • Historically, EBIT Margin has averaged 8067.19% across 5 years, with a median of 2571.29% in 2014.
  • Biggest five-year swings in EBIT Margin: soared 7295469bps in 2014 and later tumbled -5163040bps in 2016.
  • Year by year, EBIT Margin stood at 2571.29% in 2014, then rose by 11bps to 2296.88% in 2015, then tumbled by -2248bps to 53927.27% in 2016, then soared by 78bps to 11825.0% in 2017, then skyrocketed by 107bps to 862.35% in 2018.
  • Business Quant data shows EBIT Margin for ARMP at 862.35% in Q4 2018, 791.21% in Q3 2018, and 1011.74% in Q2 2018.